Literature DB >> 18303496

Genetic screening in reproductive health care.

Michael T Mennuti1.   

Abstract

Genetic screening is used to identify individuals who have genetic variations or mutations that are associated with a particular disorder. Genetic screening may be useful to plan for periodic evaluation, implementation of preventive strategies, or initiation of therapeutic interventions. Current practice is to offer carrier screening for certain genetic diseases during the preconception encounter or more commonly as part of early prenatal care.

Entities:  

Mesh：

Year:  2008        PMID： 18303496     DOI： 10.1097/GRF.0b013e318160f241

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


  6 in total

Review 1.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

2.  Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudes.

Authors:  Nigel Pereira; Michelle Wood; Emerly Luong; Allison Briggs; Michael Galloway; Rose A Maxwell; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2019-02-13       Impact factor: 3.412

Review 3.  The measurement of patient attitudes regarding prenatal and preconception genetic carrier screening and translational behavioral medicine: an integrative review.

Authors:  Jennifer J Shiroff; Mathew J Gregoski
Journal:  Transl Behav Med       Date:  2017-06       Impact factor: 3.046

Review 4.  Next-generation sequencing in the clinic: are we ready?

Authors:  Leslie G Biesecker; Wylie Burke; Isaac Kohane; Sharon E Plon; Ron Zimmern
Journal:  Nat Rev Genet       Date:  2012-11       Impact factor: 53.242

5.  Generating a taxonomy for genetic conditions relevant to reproductive planning.

Authors:  Diane M Korngiebel; Carmit K McMullen; Laura M Amendola; Jonathan S Berg; James V Davis; Marian J Gilmore; Cary O Harding; Patricia Himes; Gail P Jarvik; Tia L Kauffman; Kathleen A Kennedy; Dana Kostiner Simpson; Michael C Leo; Frances L Lynch; Denise I Quigley; Jacob A Reiss; C Sue Richards; Alan F Rope; Jennifer L Schneider; Katrina A B Goddard; Benjamin S Wilfond
Journal:  Am J Med Genet A       Date:  2016-03       Impact factor: 2.802

6.  Pregnancy as foreground in cystic fibrosis carrier testing decisions in primary care.

Authors:  Kathleen J H Sparbel; Janet K Williams
Journal:  Genet Test Mol Biomarkers       Date:  2009-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.